Skip to content

A clinical trial to study the efficacy of matrabasti in insomnia

A Randomized,Controlled, Clinical Study Of Efficacy Of Matrabasti In Anidra With Special Refrence To Primary Insomnia. - RAMA

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/029277
Enrollment
30
Registered
2020-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Matrabasti with Tila Taila for 7 days in patients having primary insomnia: Matrabasti with 60 ml Tila Taila for 7 days in ano rectal route in patients having primary insomnia Control I

Sponsors

Amruta Arjun Chavare
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient already diagnosed for primary insomnia by APA2000 diagnostic criteria • Patient who are suffering from the signs and symptoms of anidra and willing for treatment. • Subjects from either sex will be selected. • Patients between 40-60 years age group. • Subjects will be selected irrespective of socioeconomic conditions • Patient complaining of reduction in sleep time, difficulty in initiation of sleep, unsatisfactory sleep and disturbed sleep either any of these or all of these.

Exclusion criteria

Exclusion criteria: Patients suffering from anidra due to other conditions like madatyaya and abhighata Patients suffering from anidra associated with other systemic and metabolic disorders like renal diseases cardiac diseases / endocrinal diseases / tuberculosis. • Insomnia due to addiction • Insomnia due to severe psychic disorder • Lactating women • Pregnant women • Uncontrolled Diabetes Mellitus and Hypertension.

Design outcomes

Primary

MeasureTime frame
Induction of normal sleep in patients having primary insomnia and reduction of score of Athense Insomnia Scale and Insomnia Severity Index scaleTimepoint: Assesment on 0,3,5,7 th day and follow up on 15 th day

Secondary

MeasureTime frame
Induction of normal sleep in patients having primary insomniaTimepoint: 7 days

Countries

India

Contacts

Public ContactAmruta Arjun Chavare

GOVERNMENT AYURVED HOSPITAL NANDED

chavareamruta85@gmail.com9021026788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026